Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
43,689,439
-
Share change
-
+3,507,707
-
Total reported value
-
$140,676,000
-
Put/Call ratio
-
27%
-
Price per share
-
$3.22
-
Number of holders
-
53
-
Value change
-
+$11,379,799
-
Number of buys
-
35
-
Number of sells
-
13
Institutional Holders of CTI BIOPHARMA CORP - COM (CTIC) as of Q4 2020
As of 31 Dec 2020,
CTI BIOPHARMA CORP - COM (CTIC) was held by
53 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
43,689,439 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, NEA Management Company, LLC, BVF INC/IL, CAXTON CORP, VANGUARD GROUP INC, Consonance Capital Management LP, Stonepine Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, Verition Fund Management LLC, and BlackRock Inc..
This page lists
53
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.